Medical Management of Melasma: A Review with Consensus Recommendations by Indian Pigmentary Expert Group

Melasma is one of the most common hyperpigmentary disorders found mainly in women and dark-skinned patients. Sunlight, hormones, pregnancy, and genetics remain the most implicated in the causation of melasma. Although rather recalcitrant to treatment, topical agents such as hydroquinone, modified Kligman's Regime, azelaic acid, kojic acid, Vitamin C, and arbutin still remain the mainstay of therapy with sun protection being a cornerstone of therapy. There are several new botanical and non botanical agents and upcoming oral therapies for the future. There is a lack of therapeutic guidelines, more so in the Indian setup. The article discusses available evidence and brings forward a suggested treatment algorithm by experts from Pigmentary Disorders Society (PDS) in a collaborative discussion called South Asian Pigmentary Forum (SPF).

[1]  F. Ali.  Oral tranexamic acid for the treatment of melasma , 2019, Clinical and experimental dermatology.

[2]  S. Chua,et al.  Oral tranexamic acid lightens refractory melasma , 2017, The Australasian journal of dermatology.

[3]  E. Pierzchała,et al.  Comparison of efficacy of products containing azelaic acid in melasma treatment , 2016, Journal of cosmetic dermatology.

[4]  T. Thng,et al.  Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis. , 2016, Journal of the American Academy of Dermatology.

[5]  M. Rendon,et al.  Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage. , 2016, Journal of drugs in dermatology : JDD.

[6]  J. Veasey,et al.  A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma. , 2015, Cutis.

[7]  T. Padhi,et al.  Oral Tranexamic Acid with Fluocinolone-Based Triple Combination Cream Versus Fluocinolone-Based Triple Combination Cream Alone in Melasma: An Open Labeled Randomized Comparative Trial , 2015, Indian journal of dermatology.

[8]  H. Sadeghi-Bazargani,et al.  The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial , 2015, Drug design, development and therapy.

[9]  P. Arora,et al.  Hormonal profile of melasma in Indian females , 2015 .

[10]  Y. Zou,et al.  Efficacy and Safety of Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream in Chinese Patients with Melasma: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study , 2015, Clinical Drug Investigation.

[11]  Nashwa N Elfar,et al.  Efficacy of Intradermal Injection of Tranexamic Acid, Topical Silymarin and Glycolic Acid Peeling in Treatment of Melasma: A Comparative Study , 2015 .

[12]  M. Kumaran,et al.  Glycolic Acid Peels/Azelaic Acid 20% Cream Combination and Low Potency Triple Combination Lead to Similar Reduction in Melasma Severity in Ethnic Skin: Results of a Randomized Controlled Study , 2015, Indian journal of dermatology.

[13]  Z. Draelos.  A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone. , 2015, Journal of the American Academy of Dermatology.

[14]  E. Jourdan,et al.  Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. , 2015, Journal of the American Academy of Dermatology.

[15]  Evangeline B. Handog,et al.  A randomized, double‐blind, placebo‐controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos , 2014, International journal of dermatology.

[16]  D. Hexsel,et al.  Objective assessment of erythema and pigmentation of melasma lesions and surrounding areas in long-term management regimens with triple combination. , 2014, Journal of drugs in dermatology : JDD.

[17]  Q. Sun,et al.  Treatment of melasma with oral administration of compound tranexamic acid: a preliminary clinical trial , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  J. P. Castanedo-Cázares,et al.  Near‐visible light and UV photoprotection in the treatment of melasma: a double‐blind randomized trial , 2014, Photodermatology, photoimmunology & photomedicine.

[19]  M. Gold,et al.  Open-label treatment of moderate or marked melasma with a 4% hydroquinone skin care system plus 0.05% tretinoin cream. , 2013, The Journal of clinical and aesthetic dermatology.

[20]  L. Hynan,et al.  A randomized, double-blinded, placebo-controlled trial of oral Polypodium leucotomos extract as an adjunct to sunscreen in the treatment of melasma. , 2013, JAMA dermatology.

[21]  J. Na,et al.  Effect of tranexamic acid on melasma: a clinical trial with histological evaluation , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[22]  Mira Choi,et al.  Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser , 2013, The Journal of dermatological treatment.

[23]  N. Virmani,et al.  Kojic Acid vis-a-vis its Combinations with Hydroquinone and Betamethasone Valerate in Melasma: A Randomized, Single Blind, Comparative Study of Efficacy and Safety , 2013, Indian journal of dermatology.

[24]  R. Bhat,et al.  A Comparative Study of the Efficacy of 4% Hydroquinone vs 0.75% Kojic Acid Cream in the Treatment of Facial Melasma , 2013, Indian journal of dermatology.

[25]  J. H. Lee,et al.  Oral Tranexamic Acid Enhances the Efficacy of Low‐Fluence 1064‐Nm Quality‐Switched Neodymium‐Doped Yttrium Aluminum Garnet Laser Treatment for Melasma in Koreans: A Randomized, Prospective Trial , 2013, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[26]  H. Miot,et al.  Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[27]  D. Nikolic,et al.  Successful treatment of hydroquinone‐resistant melasma using topical methimazole , 2013, Dermatologic therapy.

[28]  P. Grimes,et al.  Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%. , 2013, Cutis.

[29]  H. Kar,et al.  A Comparison of Low-Fluence 1064-nm Q-Switched Nd: YAG Laser with Topical 20% Azelaic Acid Cream and their Combination in Melasma in Indian Patients , 2012, Journal of cutaneous and aesthetic surgery.

[30]  L. Azulay-Abulafia,et al.  Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long‐standing clinical severity , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[31]  S. Farshi.  Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma , 2011, Journal of cosmetic dermatology.

[32]  A. Khaiat,et al.  A randomized and placebo‐controlled study to compare the skin‐lightening efficacy and safety of lignin peroxidase cream vs. 2% hydroquinone cream , 2011, Journal of cosmetic dermatology.

[33]  F. J. González,et al.  A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma , 2011, Dermatology research and practice.

[34]  I. Majid.  MOMETASONE-BASED TRIPLE COMBINATION THERAPY IN MELASMA: IS IT REALLY SAFE? , 2010, Indian journal of dermatology.

[35]  A. Costa,et al.  Associação de emblica, licorice e belides como alternativa à hidroquinona no tratamento clínico do melasma , 2010 .

[36]  J. Halpern,et al.  Interventions for melasma. , 2010, The Cochrane database of systematic reviews.

[37]  P. Grimes,et al.  Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma. , 2010, Journal of the American Academy of Dermatology.

[38]  F. Bonte,et al.  Whitening efficacy of plant extracts including orchid extracts on Japanese female skin with melasma and lentigo senilis , 2010, The Journal of dermatology.

[39]  J. Na,et al.  Efficacy and safety of liposome‐encapsulated 4‐n‐butylresorcinol 0.1% cream for the treatment of melasma: A randomized controlled split‐face trial , 2010, The Journal of dermatology.

[40]  N. Polnikorn.  Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: A prospective study , 2010, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[41]  P. Puri,et al.  Melasma in men: a clinical, aetiological and histological study , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[42]  A. Costa,et al.  Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma * Associação de emblica, licorice e belides como alternativa à hidroquinona no tratamento clínico do melasma , 2010 .

[43]  H. Lui,et al.  A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[44]  A. Tirado-Sánchez,et al.  Efficacy of dioic acid compared with hydroquinone in the treatment of melasma , 2009, International journal of dermatology.

[45]  Evangeline B. Handog,et al.  A randomized, double‐blind, placebo‐controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women , 2009, International journal of dermatology.

[46]  A. H. and.  A COMPARATIVE STUDY TO EVALUATE THE EFFICACY OF "4% N- ACETYL GLUCOSAMINE + 2% NICOTINAMIDE" CREAM VERSUS 4% HYDROQUINONE CREAM IN THE TREATMENT OF FACIAL MELASMA: A RANDOMIZED, DOUBLE-BLIND, SPLIT-FACE CLINICAL TRIAL , 2009 .

[47]  N. Kerrouche,et al.  A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0·01%, hydroquinone 4%, tretinoin 0·05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma , 2008, The British journal of dermatology.

[48]  T. Lotti,et al.  Melasma: Successful treatment with pidobenzone 4% (K5®lipogel) , 2008, Dermatologic therapy.

[49]  M. Rendon,et al.  Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature. , 2008, Cutis.

[50]  C. Yong.  Treatment of melasma with oral administration of tranexamic acid , 2008 .

[51]  J. Ortonne,et al.  Therapeutical approaches in melasma. , 2007, Dermatologic clinics.

[52]  S. Seité,et al.  Evaluation of the effectiveness of a broad‐spectrum sunscreen in the prevention of chloasma in pregnant women , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[53]  J. Ortonne,et al.  Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial , 2007, The British journal of dermatology.

[54]  K. Hassun,et al.  A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma , 2007, Journal of cosmetic dermatology.

[55]  A. P. Kelly,et al.  Community-based trial of a triple-combination agent for the treatment of facial melasma. , 2006, Cutis.

[56]  Susan C. Taylor,et al.  A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. , 2005, Journal of drugs in dermatology : JDD.

[57]  M. Jarratt.  Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. , 2004, Cutis.

[58]  B. Moncada,et al.  A double‐blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma , 2004, International journal of dermatology.

[59]  A. Pandya,et al.  Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma , 2003, International journal of dermatology.

[60]  Susan C. Taylor,et al.  Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. , 2003, Cutis.

[61]  Alessandra Haddad,et al.  A clinical, prospective, randomized, double‐blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma , 2003, International journal of dermatology.

[62]  H. Kar.  Efficacy of beta-carotene topical application in melasma--an open clinical trial. , 2003, Indian journal of dermatology, venereology and leprology.

[63]  Kar Hk.  Efficacy of beta-carotene topical application in melasma: an open clinical trial. , 2002 .

[64]  Sun-Lim Choi,et al.  Aloesin inhibits hyperpigmentation induced by UV radiation , 2002, Clinical and experimental dermatology.

[65]  Z. Ni,et al.  Treatment of melasma with Pycnogenol® , 2002, Phytotherapy research : PTR.

[66]  H. Kim,et al.  Therapeutic effect of topical application of linoleic acid and lincomycin in combination with betamethasone valerate in melasma patients. , 2002, Journal of Korean medical science.

[67]  A. Kanwar,et al.  A Comparative Study of 20% Azelaic Acid Cream Monotherapy versus a Sequential Therapy in the Treatment of Melasma in Dark-Skinned Patients , 2002, Dermatology.

[68]  J. Wiechers,et al.  Octadecenedioic acid for a more even skin tone , 2002 .

[69]  Frcpi,et al.  Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. , 1999 .

[70]  J. Lim,et al.  Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. , 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[71]  J. Fulton,et al.  The Combination of Glycolic Acid and Hydroquinone or Kojic Acid for the Treatment of Melasma and Related Conditions , 1996, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[72]  A. Sivayathorn.  Melasma in Orientals , 1995 .

[73]  K. Graupe,et al.  The Treatment of Melasma 20% Azelaic Acid versus 4% Hydroquinone Cream , 1991, International journal of dermatology.

[74]  K. Jimbow.  N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma. , 1991, Archives of dermatology.

[75]  V. Verallo-Rowell,et al.  Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. , 1989, Acta dermato-venereologica. Supplementum.

[76]  J. Piquero-Martín,et al.  [Double-blind clinical study of the treatment of melasma with azelaic acid versus hydroquinone]. , 1988 .

[77]  E. A. González,et al.  Association of Melasma with Thyroid Autoimmunity and Other Thyroidal Abnormalities and Their Relationship to the Origin of the Melasma , 1986 .

[78]  J. Sánchez,et al.  The efficacy of a broad-spectrum sunscreen in the treatment of melasma. , 1983, Cutis.

[79]  K. Arndt,et al.  Topical use of hydroquinone as a depigmenting agent. , 1965, JAMA.